← Back
$ARTV All transactions

Artiva Biotherapeutics, Inc.

A

$ Value

$0

Shares

46,000

Price

$0

Filed

Feb 18

Insider

Name

Raymon Heather

Title

SVP, Research and Development

CIK

0002028466

Roles

Officer

Transaction Details

Transaction Date

2026-02-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

152,844

Footnotes

Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan. | Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.

Filing Info

Accession No.

0001193125-26-057674

Form Type

4

Issuer CIK

0001817241

Raymon Heather's History

Date Ticker Type Value
2026-02-15 ARTV A $0
2026-02-15 ARTV F $6K
2025-12-12 ARTV A $0
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-12-12 ARTV D
2025-11-15 ARTV F $4K
2025-08-15 ARTV F $5K

Other Insiders at ARTV (90d)

Insider Bought Sold Last
Bush Jennifer
COO, CLO, Secy, Compliance Off
2026-02-15
Horan Christopher
Chief Tech Operations Officer
2026-02-15
Sorg Elaine K. 2026-02-18
Aslan Fred
President and CEO
2026-02-15
Raymon Heather
SVP, Research and Development
2026-02-15
Banerjee Subhashis
Chief Medical Officer
2026-02-15